{"transactions":[{"id":1177750,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81062,"kind":"person","name":"Sullivan Amy","position":1,"cik":"0001887865","reported_name":"Sullivan Amy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-04T20:16:20.000Z","date":"2025-04-02","kind":"grant","planned":false,"acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control."}],"balance_after":215000,"derivative":{"exercise_price":1.07,"expiration_date":"2035-04-02","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0000905148-25-001095","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514825001095/form4.xml","form_type":"4"}},{"id":1322975,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81062,"kind":"person","name":"Sullivan Amy","position":1,"cik":"0001887865","reported_name":"Sullivan Amy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-23T23:53:56.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":10250,"price":0.8276,"value":8482.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $0.7861 to $0.90, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":84632,"source":{"system":"sec-edgar","filing":"0000905148-24-003410","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514824003410/form4.xml","form_type":"4"}},{"id":1572653,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81062,"kind":"person","name":"Sullivan Amy","position":1,"cik":"0001887865","reported_name":"Sullivan Amy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-18T20:24:57.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control."}],"balance_after":280000,"derivative":{"exercise_price":1.65,"expiration_date":"2034-03-15","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0000905148-24-000969","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514824000969/form4.xml","form_type":"4"}},{"id":1812155,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81062,"kind":"person","name":"Sullivan Amy","position":1,"cik":"0001887865","reported_name":"Sullivan Amy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Warrants (Right to Buy)","published_at":"2023-08-10T00:41:12.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":49382,"price":0.125,"value":6172.75,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023."}],"balance_after":49382,"derivative":{"exercise_price":2.47,"exercise_date":"2023-08-09","underlying":"Common Stock","underlying_shares":49382},"source":{"system":"sec-edgar","filing":"0001140361-23-038879","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036123038879/form4.xml","form_type":"4"}},{"id":1812154,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81062,"kind":"person","name":"Sullivan Amy","position":1,"cik":"0001887865","reported_name":"Sullivan Amy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-10T00:41:12.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":49382,"price":1.9,"value":93825.8,"ownership":{"direct":true},"balance_after":74382,"source":{"system":"sec-edgar","filing":"0001140361-23-038879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036123038879/form4.xml","form_type":"4"}},{"id":1941853,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81062,"kind":"person","name":"Sullivan Amy","position":1,"cik":"0001887865","reported_name":"Sullivan Amy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-22T20:26:59.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on March 20, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control."}],"balance_after":55000,"derivative":{"exercise_price":1.98,"expiration_date":"2033-03-20","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001140361-23-013076","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036123013076/form4.xml","form_type":"4"}},{"id":1944772,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81062,"kind":"person","name":"Sullivan Amy","position":1,"cik":"0001887865","reported_name":"Sullivan Amy","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-20T21:35:52.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.3207,"value":58017.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $2.18 to $2.46, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001140361-23-012596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036123012596/form4.xml","form_type":"4"}},{"id":2134876,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81062,"kind":"person","name":"Sullivan Amy","position":1,"cik":"0001887865","reported_name":"Sullivan Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-19T20:54:45.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":288152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on 10/15/2023, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control."}],"balance_after":288152,"derivative":{"exercise_price":2.55,"expiration_date":"2032-10-17","underlying":"Common Stock","underlying_shares":288152},"source":{"system":"sec-edgar","filing":"0001567619-22-018617","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000156761922018617/doc1.xml","form_type":"4"}}]}